BRAIDO, FULVIO
 Distribuzione geografica
Continente #
EU - Europa 22.712
AS - Asia 2.576
NA - Nord America 1.471
SA - Sud America 183
AF - Africa 53
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 27.001
Nazione #
IT - Italia 22.204
US - Stati Uniti d'America 1.376
SG - Singapore 1.089
CN - Cina 623
VN - Vietnam 387
FR - Francia 196
BD - Bangladesh 181
BR - Brasile 113
HK - Hong Kong 106
FI - Finlandia 80
DE - Germania 68
NL - Olanda 58
AR - Argentina 33
JP - Giappone 33
CA - Canada 31
MX - Messico 29
IQ - Iraq 26
ID - Indonesia 22
IN - India 22
ES - Italia 21
CH - Svizzera 17
GB - Regno Unito 16
PH - Filippine 11
IE - Irlanda 10
CO - Colombia 9
KE - Kenya 9
MA - Marocco 9
SA - Arabia Saudita 8
TT - Trinidad e Tobago 8
GT - Guatemala 7
NP - Nepal 7
PY - Paraguay 7
RU - Federazione Russa 7
ZA - Sudafrica 7
AT - Austria 6
EC - Ecuador 6
TR - Turchia 6
UZ - Uzbekistan 6
AU - Australia 5
HN - Honduras 5
PK - Pakistan 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
MY - Malesia 4
SE - Svezia 4
UA - Ucraina 4
VE - Venezuela 4
AZ - Azerbaigian 3
CL - Cile 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
HR - Croazia 3
JO - Giordania 3
KG - Kirghizistan 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
SN - Senegal 3
TW - Taiwan 3
UY - Uruguay 3
BE - Belgio 2
BJ - Benin 2
BO - Bolivia 2
CD - Congo 2
IL - Israele 2
MD - Moldavia 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
PL - Polonia 2
PR - Porto Rico 2
SV - El Salvador 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KY - Cayman, isole 1
LT - Lituania 1
LV - Lettonia 1
MN - Mongolia 1
NA - Namibia 1
NE - Niger 1
NI - Nicaragua 1
Totale 26.992
Città #
Genova 13.147
Genoa 5.471
Rapallo 1.871
Vado Ligure 1.422
Singapore 533
San Jose 428
Ashburn 197
Lauterbourg 183
Council Bluffs 123
Ho Chi Minh City 112
Hong Kong 102
Hanoi 89
New York 89
Beijing 86
Helsinki 72
Bordighera 63
Santa Clara 51
Frankfurt am Main 47
Amsterdam 42
Tokyo 30
Los Angeles 20
Milan 20
Da Nang 19
Dallas 19
Mexico City 17
Haiphong 16
Rome 15
Tianjin 15
Zurich 15
Buffalo 14
Boardman 13
Chicago 12
Naples 12
Biên Hòa 11
Phoenix 11
Baghdad 10
Dublin 10
Shanghai 9
Bologna 8
Can Tho 8
City of London 8
Lappeenranta 8
Orem 8
Santiago de Compostela 8
Atlanta 7
Guangzhou 7
Guatemala City 7
Jakarta 7
Seattle 7
Berlin 6
Certaldo 6
Hải Dương 6
Nairobi 6
Tashkent 6
Toronto 6
Montreal 5
Nuremberg 5
São Paulo 5
Turin 5
Belo Horizonte 4
Bắc Giang 4
Bắc Ninh 4
Cagliari 4
Cao Lanh 4
Cardiff 4
Ciudad del Este 4
Des Moines 4
Houston 4
Jeddah 4
Madrid 4
Malang 4
Munich 4
Ninh Bình 4
Paris 4
Philadelphia 4
Port of Spain 4
Richmond 4
Rio de Janeiro 4
Shenzhen 4
Tampa 4
Trieste 4
Baku 3
Bangkok 3
Bengaluru 3
Brescia 3
Charlotte 3
Chennai 3
Columbus 3
Curitiba 3
Dakar 3
Dammam 3
Dhaka 3
Guayaquil 3
Hyderabad 3
Johannesburg 3
Louisville 3
Makati City 3
Montevideo 3
Muscat 3
Orlando 3
Totale 24.700
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 335
RAPP-children: A new tool for assessing quality of life in patients with asthma and rhinitis 270
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. 207
The perception of Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) among Italian general practitioners 207
Exploring the Relationship between Disease Awareness and Outcomes in Patients with Chronic Obstructive Pulmonary Disease 205
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users 204
Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study 202
'Emergency exit' of bone-marrow-resident CD34+ DNAM-1 bright CXCR4+-committed lymphoid precursors during chronic infection and inflammation 201
Genuair® Usability Test: Results of a National Public Survey of the Elderly 200
null 200
The bacterial lysate Lantigen B reduces the number of acute episodes in patients with recurrent infections of the respiratory tract: the results of a double blind, placebo controlled, multicenter clinical trial 192
A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. 191
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 189
"Trying, But Failing" - The Role of Inhaler Technique and Mode of Delivery in Respiratory Medication Adherence 183
The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes 180
Antiallergic drugs and quality of life. 178
Sleep complaints and sleep breathing disorders in upper and lower obstructive lung diseases 177
Chronic Urticaria Patient Perspective (CUPP): The First Validated Tool for Assessing Quality of Life in Clinical Practice 177
A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). 174
An update on allergen immunotherapy and asthma 173
COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion. 173
Allergic diseases and their impact on quality of life. 172
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 171
CD4+CD25highCD127- regulatory T-cells in COPD: Smoke and drugs effect 171
Clara cell 16 protein in COPD sputum: A marker of small airways damage? 170
Allergic rhinitis and asthma ad hoc survey: clinical and psychological perspectives. 168
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol 168
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 168
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 167
The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Validation and assessment 167
Viruses and bacteria in acute asthma exacerbations--a GA² LEN-DARE systematic review. 164
RhinAsthma patient perspective: A Rasch validation study 164
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context 164
The relationship between allergen immunotherapy and omalizumab for treating asthma 163
Patient-physician relationship in the management of asthma: Multicentric approach in Latin America 163
Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation) 162
Umeclidinium for the treatment of uncontrolled asthma 162
Adherence to treatment: assessment of an unmet need in asthma. 161
Pidotimod: The state of art 161
Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases? 161
Cost-description and multiple imputation of missing values: the SATisfaction and adherence to COPD treatment (SAT) study 161
Biosimilars in allergic diseases 161
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 160
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. 160
The ARGA study with general practitioners: Impact of medical education on asthma/rhinitis management 159
Diurnal mouthpiece ventilation and nocturnal non-invasive ventilation versus tracheostomy invasive ventilation in patients with amyotrophic lateral sclerosis. 159
Determinants and impact of suboptimal asthma control in Europe: The INTERNATIONAL CROSS-SECTIONAL AND LONGITUDINAL ASSESSMENT ON ASTHMA CONTROL (LIAISON) study 156
Adherence to asthma treatments: 'We know, we intend, we advocate' 156
Disease awareness in patients with COPD: measurement and extent 156
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. 154
Minimal important difference of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) 153
Randomized controlled trials and real life studies. Approaches and methodologies: A clinical point of view 152
Minimal clinical important difference (MCID) of the Thai chronic urticaria quality of life questionnaire (CU-Q2oL) 152
Disability in moderate chronic obstructive pulmonary disease: Prevalence, burden and assessment-results from a real-life study 152
InternationaL cross-sectIonAl and longItudinal assessment on aSthma cONtrol in European adult patients--the LIAISON study protocol. 150
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 150
Coping with asthma: is the physician able to identify patient's behaviour? 149
Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity? 149
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 148
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle 147
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management 147
Why do doctors and patients not follow guidelines? 146
New therapies for allergic rhinitis 146
Impact of asthma and comorbid allergic rhinitis on quality of life and control in patients of italian general practitioners 146
RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy 145
Quality-of-life issues in survivors to anaphylactic reactions to drugs 144
Patient-reported outcomes in asthma clinical trials 144
Non-invasive ventilation in acute respiratory failure of patients with obesity hypoventilation syndrome 144
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 144
Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. 143
Recommendations for assessing patient-reported outcomes and health-related quality of life in clinical trials on allergy: a GA(2)LEN taskforce position paper. 143
Long-acting bronchodilators improve health related quality of life in patients with COPD. 143
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. 142
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide. 142
Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. 141
Does asthma control correlate with quality of life related to upper and lower airways? A real life study. 140
Does a low-density gas mixture or oxygen supplementation improve exercise training in COPD? 140
Asthma treatment: 'magic bullets which seek their own targets'. 139
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? 139
Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab 138
From "blockbusters" to "biosimilars": An opportunity for patients, medical specialists and health care providers 138
Continuing Medical Education:an international reality 138
Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 138
The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA(2)LEN review. 138
Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. 137
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis 136
“ Immunologia dell’apparato Respiratorio e metodiche di studio “ Cap 8 135
Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. 135
Aqua©: Allergy questionnaire for athletes. Development and validation 135
Phenotypes/endotypes-driven treatment in asthma 135
Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR) 134
Choosing wisely: Practical considerations on treatment efficacy and safety of asthma in the elderly 134
Transoral glossoepiglottopexy in the treatment of adult obstructive sleep apnoea: A surgical approach [Glossoepiglottoplastica con approccio trans-orale nel trattamento delle apnee ostruttive notturne nell’adulto] 134
Sleep disturbances in allergic diseases. 133
ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review. 133
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. 133
Worldwide differences on the concept of control of asthma. 132
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement 132
Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. 131
Rhinitis: Adherence to treatment and new technologies 131
Totale 15.997
Categoria #
all - tutte 90.415
article - articoli 89.583
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 832
Totale 180.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021163 0 0 0 0 0 0 0 0 0 0 0 163
2021/20222.437 127 164 117 243 52 250 119 570 182 213 106 294
2022/20232.276 249 118 21 236 326 413 52 181 395 55 184 46
2023/20241.097 61 161 24 115 98 167 90 79 57 28 96 121
2024/20253.448 45 264 131 223 486 375 328 486 184 213 343 370
2025/20267.142 735 195 838 441 828 695 1.128 321 512 632 417 400
Totale 27.701